BA vs OGEN · P/E 89, rev $89.46B vs rev $37.7K
The Boeing Company (BA) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the BA and OGEN stock pages for the full models.
Not investment advice.